— BPI Conference & Exposition is Optimal Forum to Help Scientists and Engineers Achieve New Heights Across All Phases of Bioprocessing to Advance Drug Candidates Closer to Approval —
New York – August 10, 2015 – IBC Life Sciences USA, an Informa company, announces that the 12th Annual BioProcess International (BPI) Conference & Exposition will be held October 26-29, 2015 at the Hynes Convention Center, Boston, MA. As the premier bioprocessing event in the country, BPI presents a comprehensive agenda that focuses on key topics in critical content areas assisting scientists and engineers in advancing drug candidates closer to approval.
An estimated 1,600 bioprocessing professionals stemming from big pharma, as well as large, mid-size, and emerging biotech companies are expected to attend BPI, where they will have access to more than 150 exhibitors, including solution providers, new technologies and services. Delegates can attend five keynote addresses given by recognized industry leaders who will offer their insightful vision into the biopharma market. Attendees can also listen to more than 160 prominent speakers and view over 100 scientific posters during the four-day event.
To solidify its position as the most comprehensive show of its kind, BPI 2015 will unveil new resources to further improve the delegate experience. An Ask the Regulators Open Forum will answer critical questions about regulatory expectations. To assist delegates in moving drug candidates closer to approval, 15 Bioprocessing Problem-Solving Moderated Discussions will be held. Town Hall Forums will create an environment for highly-focused industry best practice sharing. Finally, an Exposition Hall Tour will provide scientists and engineers with an extremely focused view of exhibitors to optimize their show attendance.
“BPI is a results-oriented event engineered to achieve the needs of each delegate and exhibitor. It provides a comprehensive forum for networking opportunities that can lead to new business development, as well as focused technical sessions across distinct disciplines for a personalized, curated experience,” said Barry Walsh, BPI Conference Director.
Attendees have access to six parallel tracks and are encouraged to create personalized pathways and cross-fertilize ideas with delegates from different disciplines. The six BPI conference tracks are Analytical, Formulation & Quality; Cell Culture & Upstream Processing; Drug Product Manufacturing & Fill-Finish Processing; Early Stage Biologics & Companies; Manufacturing Strategy; and Recovery & Purification. With this variety, attendees have the option to dive deep or take a big picture approach to learn about industry trends, challenges, and benchmark against the latest research developments.
To learn more about BPI or to register, visit www.IBCLifeSciences.com/BPI.
About BPI Conference & Exposition
BPI, an IBC USA conference and exposition, is the largest bioprocessing event that brings attendees new ideas, helps advance and explain technologies, and fosters partnerships in highly engaging formats to move drug candidates closer to approval. It delivers the most comprehensive science, the most innovative technologies, and the best partners enabling scientists and engineers to reach new heights of clinical and commercial success. IBC USA is an Informa company. To learn more, visit www.IBCLifeSciences.com/BPI.
Help employers find you! Check out all the jobs and post your resume.
